Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination

Shmuel Stienlauf, Michal Shoresh, Abraham Solomon, Tamar Lublin-Tennenbaum, Yaakov Atsmon, Yosef Meirovich, Ehud Katz

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Administration of vaccinia immune globulin (VIG), derived from vaccinated healthy adult volunteers, is the treatment-of-choice for patients suffering from severe complications following smallpox vaccination. The present study was aimed to determine the time interval after vaccination, at which the highest titer of neutralizing antibodies is obtained. Ninety-nine 18-year-old soldiers, immunized with vaccinia virus at birth, participated in the study, 87 of whom had detectable antibodies against vaccinia virus prior to re-vaccination. Their initial average neutralizing antibodies titer (NT50) was 27. Fourteen days after re-vaccination the titer reached 152 and then dropped to 136, 119, 110 and 87 at 21, 30, 45 and 60 d, respectively. The titers of vaccinia antibodies induced in vaccinees without detectable antibodies at the start of the study, were significantly lower and the titers observed after re-vaccination were: 62, 56, 66, 38 and 34, at 14, 21, 30, 45 and 60 d, respectively. In an additional study, 65 volunteers vaccinated at birth and again at the age of 8 years old were re-vaccinated. Fourteen days later their NT50 was higher than those vaccinated only at birth. It can be concluded that bleeding of vaccinees 14 d following re-vaccination is the preferable time for the preparation of VIG.

Original languageEnglish
Pages (from-to)201-204
Number of pages4
JournalVaccine
Volume17
Issue number3
DOIs
StatePublished - 21 Jan 1999
Externally publishedYes

Bibliographical note

Funding Information:
The dedication and help of Edi Laba and Yishai Rinat, are greatly appreciated. The study was supported by Grant Number DMAMD17-88-Z-8010 Task #8 from the US Army Medical Research and Material Command, Fort Detrick, Frederick MD. 21702-5014.

Funding

The dedication and help of Edi Laba and Yishai Rinat, are greatly appreciated. The study was supported by Grant Number DMAMD17-88-Z-8010 Task #8 from the US Army Medical Research and Material Command, Fort Detrick, Frederick MD. 21702-5014.

FundersFunder number
US Army Medical Research and Material Command21702-5014

    Keywords

    • Immunization
    • Neutralizing antibodies
    • Vaccination
    • Vaccinia virus

    Fingerprint

    Dive into the research topics of 'Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination'. Together they form a unique fingerprint.

    Cite this